FDA-Drug2024-12-11Class I
PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
Boulla LLC
Hazard
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Sold states
Nationwide within the United States
Affected count
Unknown
Manufactured in
2108 N ST #7929, Sacramento, CA, United States
Products
PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0084-2025Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief